What is the survival period for MDS transforming into acute myeloid leukemia?
Mar 28, 2023
Source: Cainiu Health
Dr. Liu Feng
Introduction
MDS refers to myelodysplastic syndromes. The survival period from myelodysplastic syndromes to acute myeloid leukemia ranges from one to ten years, varying according to individual physical conditions. In addition, timely treatment is necessary upon diagnosis of myelodysplastic syndromes, and maintaining an optimistic mindset helps delay disease progression. Furthermore, it is important to pay attention to personal protection in daily life.
MDS refers to myelodysplastic syndromes. In general, the survival period from myelodysplastic syndrome transforming into acute myeloid leukemia ranges from one to ten years, varying according to individual physical conditions. The detailed analysis is as follows:
Myelodysplastic syndrome is a heterogeneous bone marrow clonal disorder originating from hematopoietic stem cells, leading to reduced blood cell counts in the body, impaired normal hematopoiesis, and progressive bone marrow failure. When myelodysplastic syndrome transforms into acute myeloid leukemia, it usually indicates disease progression. Without timely treatment, the survival period for acute myeloid leukemia may be approximately one year. However, with appropriate conditions, active use of novel therapies, or hematopoietic stem cell transplantation, survival can be significantly prolonged—potentially up to around ten years. Due to individual differences, actual survival periods vary.
In addition, patients with myelodysplastic syndromes should receive prompt treatment. Maintaining an optimistic mindset helps slow disease progression, and attention should be paid to personal protection in daily life to prevent infections.
